Medico Remedies Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 38.91 | 41.60 | 40.91 |
Operating Expense | 35.43 | 34.64 | 36.38 |
Net Profit | 1.82 | 4.34 | 2.62 |
Net Profit Margin | 4.68 | 10.43 | 6.40 |
Earning Per Share | 0.22 | 0.52 | 0.32 |
EBIDTA | 3.41 | 7.48 | 4.45 |
Effective Tax Rate | 15.52 | 27.01 | 17.40 |
Particulars | Jun 2025 |
---|---|
Revenue | 38.91 |
Operating Expense | 35.43 |
Net Profit | 1.82 |
Net Profit Margin | 4.68 |
Earning Per Share | 0.22 |
EBIDTA | 3.41 |
Effective Tax Rate | 15.52 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 150.94 | 144.92 | 140.44 |
Operating Expenses Annual | 135.94 | 132.01 | 130.82 |
Operating Profit Annual | 17.69 | 15.04 | 13.57 |
Interest Annual | 1.16 | 0.82 | 0.75 |
Depreciation | 2.61 | 2.46 | 2.31 |
Net Profit Annual | 10.09 | 8.29 | 7.24 |
Tax Annual | 3.41 | 3.04 | 2.86 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 150.94 |
Operating Expenses Annual | 135.94 |
Operating Profit Annual | 17.69 |
Interest Annual | 1.16 |
Depreciation | 2.61 |
Net Profit Annual | 10.09 |
Tax Annual | 3.41 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.18 | 0.91 | 1.17 |
Cash Flow from Operations | 4.89 | 2.44 | 8.17 |
Cash Flow from Investing | -3.46 | -2.68 | -6.60 |
Cash Flow from Financing | -0.52 | -0.49 | -1.82 |
Cash Flow at the End | 1.09 | 0.18 | 0.91 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.18 |
Cash Flow from Operations | 4.89 |
Cash Flow from Investing | -3.46 |
Cash Flow from Financing | -0.52 |
Cash Flow at the End | 1.09 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 11.72 | 10.37 | 9.66 |
PBIT Margin (%) | 9.71 | 8.38 | 7.73 |
PBT Margin (%) | 1.34 | -1.85 | -2.57 |
Net PROFIT Margin (%) | 6.68 | 5.72 | 5.16 |
Return On Networth / Equity (%) | 17.57 | 17.23 | 18 |
Return On Networth /Employed (%) | 21.31 | 21.24 | 21.01 |
Return On Assets (%) | 14.64 | 14.47 | 14.02 |
Total Debt / Equity (X) | 0.20 | 0.19 | 0.28 |
Asset Turnover Ratio (%) | 2.19 | 2.53 | 2.72 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 11.72 |
PBIT Margin (%) | 9.71 |
PBT Margin (%) | 1.34 |
Net PROFIT Margin (%) | 6.68 |
Return On Networth / Equity (%) | 17.57 |
Return On Networth /Employed (%) | 21.31 |
Return On Assets (%) | 14.64 |
Total Debt / Equity (X) | 0.20 |
Asset Turnover Ratio (%) | 2.19 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 21.29 | 21.49 | 21.90 |
Total Current Assets Annual | 96.68 | 73.71 | 64.54 |
Non Current Assets Annual | 23.12 | 22.48 | 22.91 |
Total Shareholders Funds Annual | 62.47 | 52.37 | 43.84 |
Total Assets Annual | 119.80 | 96.20 | 87.45 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 21.29 |
Total Current Assets Annual | 96.68 |
Non Current Assets Annual | 23.12 |
Total Shareholders Funds Annual | 62.47 |
Total Assets Annual | 119.80 |
No Data Availabe